WebJun 9, 2006 · Phosphate-binding agents The substantial lack of efficacy of the treatment of hyperphosphataemia with only diet and/or dialysis makes it necessary to focus attention on substances capable of removing the excess of phosphate. 95% of renal failure patients in the advanced stage of their disease must be treated with phosphate binders. These agents work by binding to phosphate in the GI tract, thereby making it unavailable to the body for absorption. Hence, these drugs are usually taken with meals to bind any phosphate that may be present in the ingested food. Phosphate binders may be simple molecular entities (such as magnesium, aluminium, calcium, or lanthanum salts) that react with phosphate and form an insoluble compound. Phosphate binders such as sevelamer may also be polymeric structures whic…

Endocrine and Metabolic Disorders - Merck Manuals Professional Edition

WebAbstract. Several prior studies suggest that ferric compounds bind dietary phosphate and possess clinical potential as phosphate binding agents. Therefore, this study was conducted to measure the effect of several ferric compounds on intestinal phosphate binding and absorption. Balance studies lasting 2 to 4 wk were performed in normal and ... Web11 rows · Phosphate binders are used to decrease the absorption of phosphate from food in the digestive ... Initial Dosing for patients not on a phosphate binder: 800 mg to 1600 mg orally 3 t… chinese takeaways greerton

National Center for Biotechnology Information

WebPhosphate binders that contain aluminum are frequently prescribed to treat hyperphosphatemia in patients with chronic renal failure, but an accumulation of aluminum can lead to osteomalacia. To evaluate the efficacy of calcium carbonate as an alternative phosphate binder, we studied 20 patients maintained on dialysis during three consecutive … WebPhosphate Binders. Phosphate binders should be taken with meals for maximal efficacy. Patients can be instructed to tailor phosphate binder intake to the phosphate content and frequency of meals. ... The two agents appear to be equivalent in their ability to control phosphate levels. This was demonstrated in a double-blind, randomized study of ... WebCa: Calcium; CKD-MBD: Chronic kidney disease-bone and mineral disorder; CVD: Cardiovascular disease; FGF-23: Fibroblast growth factor-23; PO: Phosphate; PTH: Parathyroid hormone. “In patients with CKD Stages G3a–G5D, treatments of CKD-MBD should be based on serial assessments of PO, Ca and PTH levels considered together”.2 chinese takeaway scunthorpe